Indigenous plant Cannabis sativa: a comprehensive ethnobotanical and pharmacological review
Keywords:
Cannabis sativa, Phytochemistry, Ethnobotany, Pharmacology, ToxicologyAbstract
Cannabis sativa (L.) is a plant indigenous to Central Asia and South-East Asia. It is widely used in ethnomedicines as an anti-inflammatory, antioxidant, analgesic, anticonvulsive, antidepressant, anticancer, antitumor, neuroprotective, anti-mutagenic, anti-allergic, and antibiotic. Numerous in vitro and in vivo investigations have already established these attributes of Cannabis. Numerous toxicological studies have demonstrated the dose-dependent toxicity of C. sativa against various pests. The exact identity of the phytoconstituents of C. sativa responsible for the observed biological effects and their mode of action at the molecular level is yet to be ascertained. This review provides a comprehensive update to the ethnomedicinal, phytochemistry, pharmacological activity, and toxicological profile of Cannabis sativa.
References
Russo EB, Jiang HE, Li X, Carboni A, Del Bianco F, Mandolino G, et al. Phytochemical and genetic analyses of ancient cannabis from Central Asia. J Exp Bot. 2008; 59(15): 4171-4182.
Crocq MA. History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci. 2022; 22(3): 223-228.
Russo EB. History of cannabis and its preparations in saga science, and sobriquet. Chem Biodivers. 2007; 4(8): 1614-1648.
Zuardi AW. History of cannabis as a medicine: a review. Braz J Psychiatry. 2006; 28: 153-157.
Piluzza G, Delogu G, Cabras A, Marceddu S, Bullitta S. Differentiation between fiber and drug types of hemp (Cannabis sativa L.) from a collection of wild and domesticated accessions. Gen Resour Crop Evol. 2013; 60(8): 2331-2342.
Touw M. The religious and medicinal uses of Cannabis in China, India and Tibet. J Psychoactive Drugs. 1981; 13(1): 23-34.
Skoglund G, Nockert M, Holst B. Viking and early Middle Ages northern Scandinavian textiles proven to be made with hemp. Scient Rep. 2013; 3(1): 1-6.
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016; 7: 19.
Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in cannabis. Phytochemistry reviews. 2008; 7(3): 615-639.
Brenneisen R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In: Marijuana and the Cannabinoids. 2007; 17-49.
Taura F, Sirikantaramas S, Shoyama Y, Shoyama Y, Morimoto S. Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes. Chem Biodivers. 2007; 4(8): 1649-63.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015; 313(24): 2456-2473.
Bapat SN, Cannabis: the forgotten sacred plant of India. J Ayurveda Holistic Med. 2015; 3(5): 92-96.
Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-cancer potential of cannabinoids, terpenes, and flavonoids present in cannabis. Cancers. 2020; 12(7): 1985.
Guindon J, Hohmann, AG. The endocannabinoid system and pain. CNS Neurol Disord-Drug Targets. 2009; 8(6): 403-421.
Slatkin NE. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis. J Support Oncol. 2009; 5(5 Suppl 3): 1-9.
Viveros MP, Marco EM. Cannabinoids, anxiety and depression. Natural products II, 2007; 227-249.
Järvinen T, Pate DW, Laine K. Cannabinoids in the treatment of glaucoma. Pharmacol Ther. 2002; 95(2): 203-220.
Liang YC, Huang CC, Hsu KS. Therapeutic potential of cannabinoids in trigeminal neuralgia. Curr Drug Targets-CNS Neurol Disord. 2004; 3(6): 507-514.
Savo V, La Rocca A, Caneva G, Rapallo F, Cornara, L. Plants used in artisanal fisheries on the Western Mediterranean coasts of Italy. J Ethnobiol Ethnomed. 2013; 9(1): 1-14.
Tang K, Struik, PC, Yin X, Thouminot C, Bjelková, et al., Comparing hemp (Cannabis sativa L.) cultivars for dual-purpose production under contrasting environments. Indust Crops Prod. 2016; 87: 33-44.
Farag S, Kayser O. The cannabis plant: botanical aspects. In: Handbook of cannabis and related pathologies (pp. 3-12). Academic Press. 2017.
Basyal P, Regmi P. Ethnobotany, Taxonomy and Phytochemistry of Cannabis sativa. Int J Med Biomed Sci. 2021; 5(2): 13-19.
Happyana N, Agnolet S, Muntendam R, Van Dam, et al., Analysis of cannabinoids in laser-microdissectedtrichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry. 2013; 87: 51-59.
Huchelmann A, Boutry M, Hachez C. Plant glandular trichomes: natural cell factories of high biotechnological interest. Plant Physiol. 2017; 175(1): 6-22.
Schultes RE, Klein WM, Plowman T, Lockwood TE. Cannabis: an example of taxonomic neglect. Cannabis Culture. 1975; 21-38.
Merlin MD. Archaeological evidence for the tradition of psychoactive plant use in the old world. Econ Bot. 2003; 57(3): 295-323.
Long T, Wagner M, Demske D, Leipe C, Tarasov PE. Cannabis in Eurasia: origin of human use and Bronze Age trans-continental connections. Veget History Archaeobot. 2017; 26(2): 245-258.
Abel EL. Marihuana: the first twelve thousand years. Springer Science & Business Media. 2013.
Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M., et al, Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol. 2018; 227: 300-315.
Friedman D, Sirven JI. Historical perspective on the medical use of cannabis for epilepsy: ancient times to the 1980s. Epilepsy Behav. 2017; 70: 298-301.
Epstein HA. A natural approach to soothing atopic skin. Skinmed. 2010; 8(2): 95-97.
Mercuri AM, Accorsi CA, Bandini Mazzanti, M. The long history of Cannabis and its cultivation by the Romans in central Italy, shown by pollen records from Lago Albano and Lago di Nemi. Veget History Archaeobot. 2002; 11(4): 263-276.
Lozano I. The therapeutic use of Cannabis sativa (L.) in Arabic medicine. J Cannabis Therapeut. 2001; 1(1): 63-70.
Goutopoulos A, Makriyannis A. From cannabis to cannabinergics: new therapeutic opportunities. Pharmacol Ther. 2002; 95(2): 103-117.
Russo E, Guy GW. A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol. Med Hypotheses. 2006; 66(2): 234-246.
Tavhare S, Acharya R. Bhanga (Cannabis sativa L.) as an activity potentiator in Ayurvedic classics and Indian alchemy (Rasashastra): A critical review. Int J Ayurvedic Med. 2016; 7(3): 136-152.
Russo E. Cannabis in India: ancient lore and modern medicine. In: Cannabinoids as therapeutics. Birkhäuser Basel. 2005: 1-22.
Kuddus M, Ginawi IA, Al-Hazimi. A. Cannabis sativa: An ancient wild edible plant of India. Emirates J Food Agricult. 2013: 736-745.
Singh M, Sardesai MM. Cannabis sativa (Cannabaceae) in ancient clay plaster of Ellora Caves, India. Curr Sci. 2016: 884-891.
Akhter N, Rashid A, Murad W, Bergmeier E. Diversity and use of ethnomedicinal plants in the region of Swat, North Pakistan. J Ethnobiol Ethnomed. 2013; 9: 25.
Narcotic Drugs and Psychotropic Substances Act in India, 1985. Page 11-Chapter III:8(b).
ElSohl M, Gu W. Constituents of Cannabis sativa. Handbook of Cannabis. 2014; 3: 1093.
ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. Phytocannabinoids. 2017: 1-36.
Jin D, Dai K, Xie Z, Chen J. Secondary metabolites profiled in cannabis inflorescences, leaves, stem barks, and roots for medicinal purposes. Scient Rep. 2020; 10(1): 1-14.
Al Khoury A, Sleiman R, Atoui A, Hindieh, P, Maroun RG, Bailly JD, El Khoury A. Antifungal and anti-aflatoxigenic properties of organs of Cannabis sativa L.: relation to phenolic content and antioxidant capacities. Arch Microbiol. 2021; 203(7): 4485-4492.
Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016; 33(12): 1357-1392.
Hill AJ, Williams CM, Whalley BJ, Stephens GJ. Phytocannabinoids as novel therapeutic agents in CNS disorders. Pharmacol Ther. 2012; 133(1): 79-97.
Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin. Brit J Pharmacol. 2008; 153(2): 199-215.
Ashton CH. Pharmacology and effects of cannabis: a brief review. Brit J Psychiatry. 2001; 178(2): 101-106.
Izzo A, Borrelli F, Capasso R., Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009; 30: 515-527.
Cascio MG, Gauson LA, Stevenson LA, Ross RA, Pertwee RG. Evidence that the plant cannabinoid cannabigerol is a highly potent α2‐adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Brit J Pharmacol. 2010; 159(1): 129-141.
Pagano E, Montanaro V, Di Girolamo A, Pistone A, Altieri V, Zjawiony JK., Capasso R. Effect of non-psychotropic plant-derived cannabinoids on bladder contractility: focus on cannabigerol. Nat Prod Commun. 2015; 10(6): 1934578X1501000653.
Romano B, Borrelli F, Fasolino I, Capasso R., Piscitelli F, Cascio MG, Izzo AA. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Brit J Pharmacol. 2013; 169(1): 213-229.
De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, Di Marzo V. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther. 2008; 325(3): 1007-1015.
IbeasBih C, Chen T, Nunn AV, Bazelot M, Dallas M., Whalley BJ. Molecular targets of cannabidiol in neurological disorders. Neurother. 2015; 12(4): 699-730.
Drinić Z, Vidović S, Vladić J, Koren A, Kiprovski B, Sikora V. Effect of extraction solvent on total polyphenols content and antioxidant activity of Cannabis sativa L. Lekovitesirovine. 2018; (38): 17-21.
Wang XS, Tang CH, Chen L, Yang XQ. Characterization and antioxidant properties of hemp protein hydrolysates obtained with Neutrase®. Food Technol Biotechnol. 2009; 47(4) 428-434.
Girgih AT, Udenigwe CC, Aluko RE. In vitro antioxidant properties of hemp seed (Cannabis sativa L.) protein hydrolysate fractions. J Am Oil Chemists Soc. 2011; 88(3): 381-389.
Rashida A, Alia V, Khajuriaa M, Faiza S, Jamwala S, Lonea JF, Vyasa D. Antioxidant Analysis in Seeds of Four Different Accessions of Cannabis sativa L. from Jammu. Res Rev Biotechnol Biosci. 2020; 7: 1-10.
Girgih AT, Udenigwe CC, Aluko RE. Reverse-phase HPLC separation of hemp seed (Cannabis sativa L.) protein hydrolysate produced peptide fractions with enhanced antioxidant capacity. Plant Foods Human Nutr. 2013; 68(1): 39-46.
Irakli M, Tsaliki E, Kalivas A, Kleisiaris F, Sarrou E, Cook CM. Effect οf genotype and growing year on the nutritional, phytochemical, and antioxidant properties of industrial hemp (Cannabis sativa L.) seeds. Antioxidants. 2019; 8(10): 491.
Pontonio E, Verni M, Dingeo C, Diaz-de-Cerio E, Pinto D, Rizzello CG. Impact of enzymatic and microbial bioprocessing on antioxidant properties of hemp (Cannabis sativa L.). Antioxidants. 2020; 9(12): 1258.
Essien EE. Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L. Electr J Environ Agricult Food Chem. 2011; 11(04): 300-307.
Yan X, Tang J, dos Santos Passos C, Nurisso A, Simoes-PiresCAJiM, Fan P. Characterization of lignanamides from hemp (Cannabis sativa L.) seed and their antioxidant and acetylcholinesterase inhibitory activities. J Agricult Food Chem. 2015; 63(49): 10611-10619.
Hong S, Sowndhararajan K, Joo T, Lim C, Cho H, Kim S, Jhoo JW. Ethanol and supercritical fluid extracts of hemp seed (Cannabis sativa L.) increase gene expression of antioxidant enzymes in HepG2 cells. Asian Pacific J Reprod. 2015; 4(2): 147-152.
Vitorović J, Joković N, Radulović N, Mihajilov-Krstev T, Cvetković VJ, Jovanović N, Bernstein N. Antioxidant Activity of Hemp (Cannabis sativa L.) Seed Oil in Drosophila Melanogaster Larvae under Non-Stress and H2O2-Induced Oxidative Stress Conditions. Antioxidants. 2021; 10(6): 830.
Nafis A, Kasrati A, Jamali CA, Mezrioui N, Setzer W, Abbad A, Hassani L. Antioxidant activity and evidence for synergism of Cannabis sativa (L.) essential oil with antimicrobial standards. Indust Crops Prod. 2019; 137: 396-400.
Ahmed M, JiM, Qin P, Gu Z, Liu Y, Sikandar, A, Javeed A. Phytochemical screening, total phenolic and flavonoids contents and antioxidant activities of Citrullus colocynthis L. and Cannabis sativa L. Appl Ecol Environ Res. 2019; 17: 6961-6979.
Nadeem I, Khan AU, Asghar MN, Ashfaq M, Shahid S, Ahmed D. In vitro total antioxidant and radical scavenging activities of organic extracts from leaves, stem and inflorescence of Cannabis sativa L. Asian J Chem. 2012; 24(11): 5067-5072
Palmieri S, Fanti F, Oliva E, Viteritti E, Sergi M, Pepe A, Compagnone D. Chemical characterization and evaluation of antioxidant activity from different cultivars of Cannabis sativa L. of Abruzzo’s region. Nat Prod Res. 2022: 1-5.
Gabotti D, Locatelli F, Cusano E, Baldoni E, Genga A, Pucci L, Mattana M. Cell suspensions of Cannabis sativa (var. futura): Effect of elicitation on metabolite content and antioxidant activity. Molecules. 2019; 24(22): 4056.
Palmieri S, Maggio F, Pellegrini M, Ricci A, Serio A, Paparella A, Lo Sterzo C. Effect of the Distillation Time on the Chemical Composition, Antioxidant Potential and Antimicrobial Activity of Essential Oils from Different Cannabis sativa L. Cultivars. Molecules. 2021; 26(16): 4770.
Muscarà C, Smeriglio A, Trombetta D, Mandalari G, La Camera E, Grassi G, Circosta C. Phytochemical characterization and biological properties of two standardized extracts from a non‐psychotropic Cannabis sativa L. cannabidiol (CBD)‐chemotype. Phytother Res. 2021; 35(9): 5269-5281.
Singh V, Gupta R., Mittal A. Phytochemical, Antimicrobial, and Antioxidant Property of Cannabis sativa. World J Pharmac Res. 217; 6(16): 454-463.
Bourjot M, Zedet A, Demange B, Pudlo M, Girard-Thernier C. In vitro mammalian arginase inhibitory and antioxidant effects of amide derivatives isolated from the hempseed cakes (Cannabis sativa). Planta Med. 2016; 3(03): e64-e67.
Csakvari AC, Moisa C, Radu DG, Olariu LM, Lupitu AI, Panda AO, Copolovici DM. Green synthesis, characterization, and antibacterial properties of silver nanoparticles obtained by using diverse varieties of Cannabis sativa leaf extracts. Molecules. 2021; 26(13): 4041.
Chang Y, Zheng C, Chinnathambi A, Alahmadi TA, Alharbi SA. Cytotoxicity, anti-acute leukemia, and antioxidant properties of gold nanoparticles green-synthesized using Cannabis sativa L leaf aqueous extract. Arab J Chem. 2021; 14(4): 103060.
Shahzadi, T, Rehman S, Riaz T, Zaib M. (2020). Eco-friendly synthesis of ZnO nanoparticles using Cannabis sativa and assessment of its activities as efficient dyes removal and antioxidant agent. Int J Environ Anal Chem. 2020: 1-19.
Hinz B, Ramer R. Anti‐tumour actions of cannabinoids. Brit J Pharmacol. 2019; 176(10): 1384-1394.
Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle. 2020; 19(9): 961-989.
Velasco G, Hernández-Tiedra S, Dávila D, Lorente M. The use of cannabinoids as anticancer agents. Progress Neuro-Psychopharmacol Biol Psych. 2016; 64: 259-266.
Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nature Rev Cancer. 2012; 12(6): 436-444.
Guzma M. Cannabinoids: potential anticancer agents. Nature Rev Cancer. 2003; 3(10): 745-755.
Hamdani SS, Bhat BA, Nissar S. Ethnobotanical study of medicinal plants of Kashmir Valley, India having anticancer properties. Int J Res Appl Sci Biotechnol. 2020; 7(4): 84-91.
Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA. Antineoplastic activity of cannabinoids. J Nat Cancer Inst. 1975; 55(3): 597-602.
Hinz B, Ramer R. Cannabinoids as anticancer drugs: current status of preclinical research. Brit J Cancer. 2022: 1-13.
Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharmacy Ther. 2017; 42(3): 180.
Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Di Marzo V. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006; 318(3): 1375-1387.
Caffarel MM, Sarrió D, Palacios J, Guzmán M, Sánchez C. Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. Cancer Res. 2006; 66(13): 6615-6621.
McAllister SD, Christian RT, Horowitz MP, Garcia A, Desprez PY. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol Cancer Ther. 2007; 6(11): 2921-2927.
Takeda S, Yoshida K, Nishimura H, Harada M, Okajima S, Miyoshi H, Aramaki H. Δ9-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ). Chem Res Toxicol. 2013; 26(7): 1073-1079.
Sharma UR, Sharma N. Green Synthesis, Anti-cancer and Corrosion Inhibition Activity of Cr2O3 Nanoparticles. Biointerf Res Appl Chem. 2021; 11: 8402-8412.
Zaka M, Hashmi SS, Siddiqui MA, Rahman L, Mushtaq S, AliH, Abbasi BH. Callus-mediated biosynthesis of Ag and ZnO nanoparticles using aqueous callus extract of Cannabis sativa: Their cytotoxic potential and clinical potential against human pathogenic bacteria and fungi. Green Processing Synthesis. 2021; 10(1): 569-584.
Go YY, Kim SR, Kim, DY, Chae SW, Song JJ. Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Scient Rep. 2020; 10(1): 1-11.
Sharma M., Hudson JB, Adomat H, Guns E, Cox ME. In vitro anticancer activity of plant-derived cannabidiol on prostate cancer cell lines. Pharmacol Pharmacy. 2014; 5(08): 806.
Anis O, Vinayaka AC, Shalev N, Namdar D, Nadarajan S, Anil SM et al. Cannabis-derived compounds cannabichromene and Δ9-tetrahydrocannabinol interact and exhibit cytotoxic activity against urothelial cell carcinoma correlated with inhibition of cell migration and cytoskeleton organization. Molecules. 2021; 26(2): 465.
Rožanc J, Kotnik P, Milojević M, Gradišnik L, Knez Hrnčič, M, Knez Z, Maver U. Different Cannabis sativa extraction methods result in different biological activities against a colon cancer cell line and healthy colon cells. Plants. 2021; 10(3): 566.
McKallip RJ, Nagarkatti M, Nagarkatti PS. Δ-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol. 2005; 174(6): 3281-3289.
Nissen L, Zatta A, Stefanini I, Grandi S, Sgorbati B, Biavati B, Monti A. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.). Fitoterapia. 2010; 81(5): 413-419.
Lone TA, Lone RA. Extraction of cannabinoids from Cannabis sativa L. plant and its potential antimicrobial activity. Univ J Med Dent. 2012; 1: 51-55.
Novak J, Zitterl‐Eglseer K, Deans SG, Franz CM. Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity. Flavour Fragrance J. 2001; 16(4): 259-262.
Khan BA, Wang J, Warner P, Wang H. Antibacterial properties of hemp hurd powder against E. coli. J Appl Polymer Sci. 2015: 132(10).
Gildea L, Ayariga JA, Ajayi OS, Xu J, Villafane R, Samuel-Foo M. Cannabis sativa CBD Extract Shows Promising Antibacterial Activity against Salmonella typhimurium and S. newington. Molecules. 2022; 27(9): 2669.
Wasim K, Haq I, Ashraf M. Antimicrobial studies of the leaf of cannabis sativa L. Pakistan J Pharmac Sci. 1995; 8(1): 29-38.
Satyal P, Setzer WN. Chemotyping and determination of antimicrobial, insecticidal, and cytotoxic properties of wild-grown Cannabis sativa from Nepal. J Med Active Plants. 2014; 3(1): 9-16.
Singh P, Pandit S, Garnaes J, Tunjic S, Mokkapati VRSS, Sultan A et al. Green synthesis of gold and silver nanoparticles from Cannabis sativa (industrial hemp) and their capacity for biofilm inhibition. Int J Nanomed. 2018; 13: 3571-3591.
Chouhan S, Guleria S. Green synthesis of AgNPs using Cannabis sativa leaf extract: Characterization, antibacterial, anti-yeast and α-amylase inhibitory activity. Mater Sci Energy Technol. 2020; 3: 536-544.
Tabari MA, Khodashenas A, Jafari M., Petrelli R, Cappellacci L, Nabissi M et al. Acaricidal properties of hemp (Cannabis sativa L.) essential oil against Dermanys susgallinae and Hyalomma dromedarii. Indust Crops Prod. 2020; 147: 112238.
Maurya P, Mohan L, Sharma P, Srivastava CN. Larval susceptibility of Aloe barbadensis and Cannabis sativa against Culex quinquefasciatus, the filariasis vector. J Environ Biol. 2008; 29(6): 941-943.
Pavela R. Larvicidal property of essential oils against Culexquinquefasciatus Say (Diptera: Culicidae). Indust Crops Prod. 2009; 30(2): 311-315.
Rossi P, Cappelli A, Marinelli O, Valzano M, Pavoni L, Bonacucina G et al. Mosquitocidal and anti-inflammatory properties of the essential oils obtained from monoecious, male, and female inflorescences of hemp (Cannabis sativa L.) and their encapsulation in nanoemulsions. Molecules. 2020; 25(15): 3451.
Benelli G, Pavela R, Petrelli R, Cappellacci L, Santini G, Fiorini D et al. The essential oil from industrial hemp (Cannabis sativa L.) by-products as an effective tool for insect pest management in organic crops. Indust Crops Prod. 2018; 122: 308-315.
Bedini S, Flamini G, Cosci F, Ascrizzi R, Benelli G, Conti B. Cannabis sativa and Humuluslupulus essential oils as novel control tools against the invasive mosquito Aedesalbopictus and fresh water snail Physellaacuta. Indust Crops Prod. 2016; 85: 318-323.
Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Progress Neuro-Psychopharmacol Biol Psych. 2004; 28(5): 849-863.
Gonzalez R. Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev. 2007; 17: 347-361.
Vadhan NP, Hart CL, van Gorp WG, Gunderson EW, Haney M, Foltin RW. Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol. 2007; 29(4): 357-364.
Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. 2005; 81(2): 319-330.
Pope HG, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA. 1996; 275(7): 521-527.
Almeida PP, Novaes MAFP, Bressan RA, Lacerda ALTD. Executive functioning and cannabis use. Braz J Psychiatry. 2008; 30: 69-76.
McHale S, Hunt N. Executive function deficits in short‐term abstinent cannabis users. Human Psychopharmacol Clin Exp. 2008; 23(5): 409-415.
Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, et al. Brain imaging study of the acute effects of Δ 9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology. 2008; 196: 119-131.
Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addiction Biol. 2008; 13(2): 196-212.
Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psych. 2001; 158(12): 2033-2037.
Tournier M, Sorbara F, Gindre C, Swendsen JD, Verdoux H. Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psych Res. 2003; 118(1): 1-8.
Pedersen W. Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psych Scand. 2008; 118(5): 395-403.
Luzi S, Morrison PD, Powell J, Di Forti M, Murray RM. What is the mechanism whereby cannabis use increases risk of psychosis? Neurotox Res. 2008; 14: 105-112.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
